Arcadia Biosciences, Inc.
Arcadia Biosciences, Inc. (RKDA) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · RKDA · as of Jun 8, 2026
Activity summary
Buy transactions
6
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
∞
Buy/Sell (by trades)
Overall sentiment
Arcadia Biosciences, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
RKDA insider buying and selling by quarter
RKDA insider selling · RKDA insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Recent insider transactions
RKDA executive sell shares · RKDA board member insider trading · RKDA insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Feb 3, 2025 | Kawakami Mark CFO | Purchase | 700 | $2K | Form 4 |
| Feb 3, 2025 | Schaefer Thomas J. CEO | Purchase | 700 | $2K | Form 4 |
| Aug 1, 2024 | Kawakami Mark CFO | Purchase | 700 | $1K | Form 4 |
| Aug 1, 2024 | Schaefer Thomas J. CEO | Purchase | 700 | $1K | Form 4 |
| Feb 1, 2024 | Schaefer Thomas J. CFO | Purchase | 700 | $1K | Form 4 |
| Aug 4, 2023 | Schaefer Thomas J. CFO | Purchase | 649 | $2K | Form 4 |
| Feb 1, 2023 | Schaefer Thomas J. CFO | Purchase | 700 | $161 | Form 4 |
| Aug 1, 2022 | Haley Pamela CFO | Purchase | 700 | $490 | Form 4 |
| Aug 3, 2020 | Plavan Matthew T CEO | Purchase | 585 | $2K | Form 4 |
| Aug 3, 2020 | Shultz Randall CTO | Purchase | 700 | $2K | Form 4 |
| Aug 3, 2020 | Haley Pamela CFO | Purchase | 700 | $2K | Form 4 |
| Feb 3, 2020 | Haley Pamela CFO | Purchase | 700 | $1K | Form 4 |
| Feb 3, 2020 | Reiter Sarah Chief Commercial Officer | Purchase | 700 | $1K | Form 4 |
| Feb 3, 2020 | Plavan Matthew T CEO | Purchase | 700 | $1K | Form 4 |
| Dec 23, 2019 | Reiter Sarah Chief Commercial Officer | Purchase | 900 | $5K | Form 4 |
| Nov 19, 2019 | Reiter Sarah Chief Commercial Officer | Purchase | 1,000 | $5K | Form 4 |
| Sep 23, 2019 | Plavan Matthew T CEO | Purchase | 2,000 | $11K | Form 4 |
| Sep 17, 2019 | Comcowich Kevin Director | Purchase | 5,000 | $29K | Form 4 |
| Sep 10, 2019 | Plavan Matthew T CEO | Purchase | 1,000 | $7K | Form 4 |
| Sep 10, 2019 | Plavan Matthew T CEO | Purchase | 1,000 | $6K | Form 4 |
Reiter Sarah
Chief Commercial Officer
Date
Feb 3
Shares
700
Price
$1.72
Value
$1K
Reiter Sarah
Chief Commercial Officer
Date
Dec 23
Shares
900
Price
$5.95
Value
$5K
Reiter Sarah
Chief Commercial Officer
Date
Nov 19
Shares
1,000
Price
$4.52
Value
$5K
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About RKDA insider trading
RKDA insider trades
Arcadia Biosciences, Inc. (RKDA) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including RKDA. Over the past 12 months, 0 insiders have filed transactions with the SEC. RKDA insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Arcadia Biosciences, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
RKDA insider trading · 5 questionsThe insiders of Arcadia Biosciences, Inc. (RKDA) include executives and directors such as RKDA, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026